完成翻译。
Completing the Translation.
机构信息
RMCC Consulting, LLC, Chester, New Jersey, USA.
University of Michigan Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.
出版信息
Oncologist. 2020 Mar;25(3):183-185. doi: 10.1634/theoncologist.2019-0650. Epub 2019 Oct 16.
Abstract
Comprehensive standards and guidelines for generating and reporting laboratory results are needed, especially as related to the translation of biology to precision medicine. This commentary focuses on the topic, highlighting a new study that investigated laboratories reporting next‐generation sequencing results to clinicians.
摘要
需要制定全面的实验室结果生成和报告标准和指南，特别是在将生物学转化为精准医学方面。本评论聚焦于这一主题，重点介绍了一项新的研究，该研究调查了向临床医生报告下一代测序结果的实验室。
相似文献
1
Completing the Translation.完成翻译。
Oncologist. 2020 Mar;25(3):183-185. doi: 10.1634/theoncologist.2019-0650. Epub 2019 Oct 16.
2
The Sequencing Quality Control 2 study: establishing community standards for sequencing in precision medicine.测序质量控制2研究：建立精准医学中测序的社区标准。
Genome Biol. 2021 Nov 8;22(1):306. doi: 10.1186/s13059-021-02528-3.
3
Clinical testing should be individualized, not based on populations.临床检测应该个体化，而非基于群体。
J Clin Invest. 2019 Sep 3;129(9):3472-3473. doi: 10.1172/JCI130903.
4
Circulating tumor DNA for personalized lung cancer monitoring.用于个性化肺癌监测的循环肿瘤DNA
BMC Med. 2017 Aug 17;15(1):157. doi: 10.1186/s12916-017-0921-6.
5
[Clinical Utility of Circulating Tumor DNA Analysis for Precision Medicine in Patients with Advanced Gastrointestinal Cancer].循环肿瘤DNA分析在晚期胃肠道癌患者精准医学中的临床应用
Gan To Kagaku Ryoho. 2021 Oct;48(10):1191-1196.
6
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.循环肿瘤 DNA 分析作为 III 期结肠癌辅助治疗复发风险和获益的标志物。
JAMA Oncol. 2019 Dec 1;5(12):1710-1717. doi: 10.1001/jamaoncol.2019.3616.
7
Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.游离循环肿瘤DNA补充组织活检用于识别可靶向突变：对精准医学的意义及结果协调的考量
Lung Cancer. 2017 Sep;111:135-138. doi: 10.1016/j.lungcan.2017.06.015. Epub 2017 Jun 23.
8
Precision Monitoring by Next-Generation Sequencing in Lymphoma: Circulating Tumor DNA as a New Biomarker.淋巴瘤中下一代测序的精准监测：循环肿瘤DNA作为一种新型生物标志物
Oncology (Williston Park). 2016 Aug;30(8):745-6.
9
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy.液体活检推动非小细胞肺癌精准治疗。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801809. doi: 10.1177/1533033818801809.
10
[Precision Medicine for Advanced Solid Malignancies Based on Circulating Tumor DNA Analysis].基于循环肿瘤DNA分析的晚期实体恶性肿瘤精准医学
Gan To Kagaku Ryoho. 2020 Dec;47(12):1645-1652.
本文引用的文献
1
Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay Discordance.四项血浆NGS检测与肿瘤的正交比较表明技术因素是检测不一致的主要来源。
JCO Precis Oncol. 2019 Dec;3:1-9. doi: 10.1200/PO.18.00191.
2
Does Testing Error Underlie Liquid Biopsy Discordance?检测误差是液体活检不一致的原因吗？
JCO Precis Oncol. 2019 Dec;3:1-3. doi: 10.1200/PO.18.00408.
3
From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.从体细胞变异到精准肿瘤学：下一代测序的循环肿瘤 DNA 分析报告实践研究。
Oncologist. 2020 Mar;25(3):218-228. doi: 10.1634/theoncologist.2019-0239. Epub 2019 Aug 30.
4
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer.液体活检在非小细胞肺癌治疗决策指导中的价值
Front Oncol. 2019 Mar 5;9:129. doi: 10.3389/fonc.2019.00129. eCollection 2019.
5
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.液体活检在晚期非小细胞肺癌（NSCLC）中的应用：国际肺癌研究协会（IASLC）立场文件。
J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6.
6
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.实体瘤肿瘤特异性临床基因组分析中克隆性造血基因突变的发生率。
JAMA Oncol. 2018 Nov 1;4(11):1589-1593. doi: 10.1001/jamaoncol.2018.2297.
7
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.由于克隆性造血导致的血浆基因分型假阳性。
Clin Cancer Res. 2018 Sep 15;24(18):4437-4443. doi: 10.1158/1078-0432.CCR-18-0143. Epub 2018 Mar 22.
8
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.癌症患者循环肿瘤 DNA 分析：美国临床肿瘤学会和美国病理学家学会联合审查。
J Clin Oncol. 2018 Jun 1;36(16):1631-1641. doi: 10.1200/JCO.2017.76.8671. Epub 2018 Mar 5.
9
Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.患者配对样本在 2 种商业液体活检检测中的一致性。
JAMA Oncol. 2018 Jun 1;4(6):868-870. doi: 10.1001/jamaoncol.2017.4027.
10
Clinical applications of urinary cell-free DNA in cancer: current insights and promising future.尿游离DNA在癌症中的临床应用：当前见解与光明前景
Am J Cancer Res. 2017 Nov 1;7(11):2318-2332. eCollection 2017.
Zotero 插件